Fusion Pharmaceuticals Inc. (FUSN)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Avidity Partners Management

David Witzke And Michael Gregory

6,500,328 $62,468,152 +13% 2.27%
2.
Deerfield Management

James E. Flynn

6,401,000 $61,513,610 +127% 1.13%
3.
OrbiMed Advisors

Samuel Isaly

3,122,770 $30,009,820 0.59%
4. 2,947,809 $28,328,444 8.72%
5.
Perceptive Advisors

Joseph Edelman

2,751,395 $26,440,905 0.59%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.03 44,400 Director 56,400 2022-08-11 Filing
$7.99 2,829 Director 12,000 2021-08-23 Filing
$8.05 3,000 Director 9,171 2021-08-19 Filing
$8.05 171 Director 6,171 2021-08-18 Filing
$8.10 6,000 Director 6,000 2021-08-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.03 4,511 Officer, Director 318,147 2022-04-27 Filing
$6.07 2,147 Officer, Director 322,658 2022-04-26 Filing
$6.03 2,036 Officer, Director 324,805 2022-04-25 Filing
$6.01 922 Officer, Director 326,841 2022-04-21 Filing
$6.02 367 Officer, Director 327,763 2022-04-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,886,153 $104,615,930 0.25%
2. 5,313,294 $51,060,755 0%
3. 3,670,516 $35,273,659 0.8%
4. 3,116,966 $29,954,043 0.03%
5. 2,551,794 $24,522,740 0.39%
News See All